Mutant p53 Enhances Nuclear Factor κB Activation by Tumor Necrosis Factor α in Cancer Cells
Open Access
- 15 March 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 67 (6), 2396-2401
- https://doi.org/10.1158/0008-5472.can-06-2425
Abstract
Mutations in the p53 tumor suppressor are very frequent in human cancer. Often, such mutations lead to the constitutive overproduction of mutant p53 proteins, which may exert a cancer-promoting gain of function. We now report that cancer-associated mutant p53 can augment the induction of nuclear factor κB (NFκB) transcriptional activity in response to the cytokine tumor necrosis factor α (TNFα). Conversely, down-regulation of endogenous mutant p53 sensitizes cancer cells to the apoptotic effects of TNFα. Analysis of human head and neck tumors and lung tumors reveals a close correlation between the presence of abundant mutant p53 proteins and the constitutive activation of NFκB. Together, these findings suggest that p53 mutations may promote cancer progression by augmenting NFκB activation in the context of chronic inflammation. [Cancer Res 2007;67(6):2396–401]Keywords
Other Versions
This publication has 19 references indexed in Scilit:
- Nuclear factor-κB in cancer development and progressionNature, 2006
- NF-κB inhibition: A double-edged sword in cancer?European Journal Of Cancer, 2006
- Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-κB, but not c-Jun N-terminal kinase and activated protein-1Molecular Carcinogenesis, 2005
- Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expressionOncogene, 2005
- The p53 pathway: positive and negative feedback loopsOncogene, 2005
- Transactivation of the EGR1 Gene Contributes to Mutant p53 Gain of FunctionCancer Research, 2004
- Inhibition of NF-κB in cancer cells converts inflammation- induced tumor growth mediated by TNFα to TRAIL-mediated tumor regressionCancer Cell, 2004
- NF-κB functions as a tumour promoter in inflammation-associated cancerNature, 2004
- A System for Stable Expression of Short Interfering RNAs in Mammalian CellsScience, 2002
- Role of NF-κB in p53-mediated programmed cell deathNature, 2000